These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6642424)

  • 1. Failure of diazepam to affect growth hormone and prolactin in acromegalics.
    Ajlouni KM
    Horm Res; 1983; 18(4):186-90. PubMed ID: 6642424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of Ritalin, CB-154 and various drugs of serum GH in acromegalics (author's transl)].
    Kanatsuka A; Makino H; Matsushima Y; Osegawa M; Yamamoto M; Kumagai A
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):636-47. PubMed ID: 99332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response of growth hormone and prolactin to oral diazepam in diabetics.
    Ajlouni K; El-Khateeb M; El-Zaheri MM; El-Najdawi A
    J Endocrinol Invest; 1982; 5(3):157-9. PubMed ID: 7108150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects.
    Ferrari C; Barbieri C; Caldara R; Rampini P; Paracchi A; Boghen M; Rauhe WG
    Clin Pharmacol Ther; 1983 Jul; 34(1):74-8. PubMed ID: 6861440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J; Límanová Z; Srámková J
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glucose of growth hormone, prolactin and thyroid-stimulating hormone response to diazepam in normal subjects.
    Ajlouni K; El-Khateeb M
    Horm Res; 1980; 13(3):160-4. PubMed ID: 7203397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulation.
    Ferrari C; Rampini P; Paracchi A; Boghen M; Mailland F
    Eur J Clin Pharmacol; 1985; 27(6):707-11. PubMed ID: 3921384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term use of parlodel in acromegaly].
    Pisarskaia IV; Zefirova GS; Ibragimova GV
    Ter Arkh; 1984; 56(10):107-10. PubMed ID: 6523351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in man.
    Goldman JA; Molitch ME; Thorner MO; Vale W; Rivier J; Reichlin S
    J Endocrinol Invest; 1987 Aug; 10(4):397-406. PubMed ID: 3119697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of naloxone to alter growth hormone and prolactin levels in acromegalic and in hyperprolactinaemic patients.
    Blankstein J; Reyes F; Winter J; Faiman C
    Clin Endocrinol (Oxf); 1979 Nov; 11(5):475-9. PubMed ID: 391445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hyperprolactinemia and acromegaly with lisuride].
    Berezin M; Elchalal U; Olchovsky D
    Harefuah; 1989 Jun; 116(12):634-7. PubMed ID: 2792946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.
    Camanni F; Massara F; Belforte L; Rosatello A; Molinatti GM
    J Clin Endocrinol Metab; 1977 Mar; 44(3):465-73. PubMed ID: 838847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dopamine on plasma growth hormone and prolactin concentrations under anaesthesia.
    Mikawa K; Kusunoki M; Obara H; Iwai S
    J Int Med Res; 1988; 16(6):403-12. PubMed ID: 3234595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegaly.
    Dallabonzana D; Liuzzi A; Oppizzi G; Verde G; Chiodini PG; Dorow R; Horowski R
    J Endocrinol Invest; 1985 Apr; 8(2):147-51. PubMed ID: 4031381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of dopaminergic stimulation on growth hormone and prolactin in the treatment of acromegaly].
    Nedvídková J; Felt V
    Vnitr Lek; 1980 Oct; 26(10):988-93. PubMed ID: 7467150
    [No Abstract]   [Full Text] [Related]  

  • 20. [Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine].
    Carmina E; Lanzara P; Lo Coco R; Longo RA; Jannì A
    Arch Sci Med (Torino); 1979; 136(3):421-5. PubMed ID: 549547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.